Matthew L. Hemming, Ph.D.
Affiliations: | 2007 | Harvard University, Cambridge, MA, United States |
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=1Google:
"Matthew Hemming"Mean distance: 17.66 (cluster 31) | S | N | B | C | P |
Parents
Sign in to add mentor| Dennis J. Selkoe | grad student | 2007 | Harvard | |
| (Regulation of amyloid -beta protein levels by proteolytic degradation and its implications for Alzheimer's disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hemming ML, Elias JE, Gygi SP, et al. (2009) Identification of beta-secretase (BACE1) substrates using quantitative proteomics. Plos One. 4: e8477 |
| Hemming ML, Elias JE, Gygi SP, et al. (2008) Proteomic profiling of gamma-secretase substrates and mapping of substrate requirements. Plos Biology. 6: e257 |
| Hemming ML, Patterson M, Reske-Nielsen C, et al. (2007) Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease. Plos Medicine. 4: e262 |
| Hemming ML, Selkoe DJ, Farris W. (2007) Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease. Neurobiology of Disease. 26: 273-81 |
| Hemming ML, Selkoe DJ. (2005) Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. The Journal of Biological Chemistry. 280: 37644-50 |
| Farris W, Leissring MA, Hemming ML, et al. (2005) Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein. Biochemistry. 44: 6513-25 |